Proficio Capital Partners LLC acquired a new position in shares of Varex Imaging Co. (NASDAQ:VREX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 29,195 shares of the company’s stock, valued at approximately $426,000. Proficio Capital Partners LLC owned 0.07% of Varex Imaging as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. FMR LLC boosted its stake in Varex Imaging by 4,739.2% during the third quarter. FMR LLC now owns 200,341 shares of the company’s stock worth $2,388,000 after buying an additional 196,201 shares during the period. Barclays PLC boosted its stake in Varex Imaging by 15.3% during the third quarter. Barclays PLC now owns 97,883 shares of the company’s stock worth $1,166,000 after buying an additional 12,966 shares during the period. Point72 Asset Management L.P. purchased a new position in Varex Imaging during the third quarter worth $415,000. BNP Paribas Financial Markets boosted its stake in Varex Imaging by 1,359.9% during the third quarter. BNP Paribas Financial Markets now owns 52,295 shares of the company’s stock worth $623,000 after buying an additional 48,713 shares during the period. Finally, Weiss Asset Management LP purchased a new position in Varex Imaging during the third quarter worth $2,593,000.
Varex Imaging Stock Down 2.1 %
NASDAQ:VREX opened at $12.54 on Tuesday. Varex Imaging Co. has a twelve month low of $10.19 and a twelve month high of $18.30. The company has a market cap of $516.65 million, a price-to-earnings ratio of -10.72 and a beta of 0.56. The stock has a fifty day simple moving average of $13.54 and a 200-day simple moving average of $13.40. The company has a current ratio of 4.36, a quick ratio of 2.50 and a debt-to-equity ratio of 1.02.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on VREX. StockNews.com upgraded Varex Imaging from a “hold” rating to a “buy” rating in a research report on Friday, February 7th. Oppenheimer decreased their target price on Varex Imaging from $30.00 to $23.00 and set an “outperform” rating for the company in a research report on Friday, February 7th. Finally, B. Riley reiterated a “buy” rating and set a $22.00 target price (up from $21.00) on shares of Varex Imaging in a research report on Friday, February 7th.
Read Our Latest Report on VREX
Varex Imaging Profile
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Read More
- Five stocks we like better than Varex Imaging
- 3 Dividend Kings To Consider
- How to Protect Your Portfolio When Inflation Is Rising
- Investing In Preferred Stock vs. Common Stock
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How to Invest in Insurance Companies: A GuideĀ
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.